Abstract
Objective
To determine the event-free survival (EFS), overall survival (OS) and predictors of outcome in pediatric anaplastic large cell lymphoma treated with a uniform protocol.
Method
This hospital record review was done between June, 2016 to March, 2019 and data was extracted from January, 2003 to May, 2016 for anaplastic large cell lymphoma (ALCL) in patients aged 1 to 18 years (n=27). EFS and OS were calculated by the Kaplan Meier method. Cox proportional model and the Cox regression model were used for univariate analysis and multivariate analysis respectively.
Results
EFS and OS at three years was 70.4% (CI: 0.49–0.84) and 77.2% (CI: 0.56 −0.89), respectively. On univariate analysis stage III and IV, hemoglobin less than 10 g/dL and presence of pleural effusion predicted lower survival. On multivariate analysis, pleural effusion was a significant predictor of low EFS and OS.
Conclusion
Pleural effusion is a potential clinical marker of poor outcome among children with anaplastic large cell lymphoma.
Similar content being viewed by others
References
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016;127: 2375–90.
Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131: 39–49.
Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of Children’s Cancer Group Study 5941. Pediatr Blood Cancer. 2009;52: 335–9.
Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 2001;97: 3699–706.
Rosolen A, Pillon M, Garaventa A, Burnelli R, d’Amore ES, Giuliano M, et al. Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer. 2005;104: 2133–40.
Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med. 2011; 364:775–6.
Mossé YP, Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children’s Oncology Group phase 1 consortium study. Lancet Oncol. 2013;14: 472–80.
Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin’s lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7: 186–93.
Lakshmaiah KC, Guruprasad B, Shah A, Kavitha S, Abraham LJ, et al. Anaplastic large cell lymphoma: A single institution experience from India. J Cancer Res Ther. 2013;9: 649–52.
Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-hodgkin’s lymphoma. N Engl J Med. 1997;337: 1259–66.
Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94: 3294–306.
Damm-Welk C, Pillon M, Woessmann W, Mussolin L. Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK. Front Biosci Sch Ed. 2015;7: 205–16.
Pillon M, Gregucci F, Lombardi A, Santoro N, Piglione M, Sala A, et al. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood. Pediatr Blood Cancer. 2012;59: 828–33.
Alexander S, Kraveka JM, Weitzman S, Lowe E, Smith L, Lynch JC, et al. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2014; 61:2236–42.
Ceppi F, Ortiz R, Antillón F, Vasquez R, Gomez W, Gamboa J, et al. Anaplastic large cell lymphoma in Central America: A report from the Central American Association of Pediatric Hematology Oncology (AHOPCA): Treatment of ALCL: A Report From a LMIC. Pediatr Blood Cancer. 2016;63: 78–82.
Resham S, Khan R, Ashraf S, Rizvi A, Altaf S. Clinical features and treatment outcomes of children with anaplastic large cell lymphoma in Pakistan: A multicenter study. J Pediatr Hematol Oncol. 2019;41: 5.
Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin’s disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer. 2006;46: 26–34.
Lowe EJ, Gross TG. Anaplastic large cell lymphoma in children and adolescents. Pediatr Hematol Oncol. 2013;30: 509–19.
Le Deley M-C, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, et al. Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study. Blood. 2008;111: 1560–6.
Author information
Authors and Affiliations
Contributions
AP: designed the research study, analysed the data, drafted the paper; DP: analyzed the data and drafted the paper; MCS,ST: acquisition and interpretation of the data for the paper, drafted the paper; SB: conception and designed the research study, analyzed the data, drafted the paper. All authors contributed to the drafting of the work, finally approved the work and agreed to be accountable for integrity of the data.
Corresponding author
Ethics declarations
Institutional Ethics Committee of AIIMS, Delhi; No. IESC/T-331, June 23, 2015.
Rights and permissions
About this article
Cite this article
Patel, A., Pushpam, D., Sharma, M. et al. Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma. Indian Pediatr 57, 523–526 (2020). https://doi.org/10.1007/s13312-020-1849-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1849-z